IRD · Opus Genetics, Inc.
$3.78
+0.07 (+1.89%)
At close · Aug 3
Market Cap
$301.98M
Shares
81.40M
Share-repurchase activity from the company's own XBRL filings — cash spent buying back common stock per fiscal year and per recent quarter, share counts where the company tagged them, and the buyback program's authorization — paired with the company's at-the-market (ATM) equity offering programs, the dilution side of the same picture. Repurchase amounts come exclusively from tagged SEC data; program figures with no tagged equivalent (untagged authorizations and all ATM figures) are read from the filing's own text and shown only after verification.
Program Authorized
$50,000,000
as of 2023-08-10
· not restated in filings since 2024-05-10
Equity Offering (ATM) Programs
| Program Established | Capacity | Remaining | As of | Runs Through | Source |
|---|---|---|---|---|---|
| 2025-01-13 | $40,000,000 | — | 2025-12-31 | — | 10-K , filed 2026-03-12 |
Repurchase History
| Fiscal Year Ended | Cash Spent | Source | ||
|---|---|---|---|---|
| 2014-03-31 | $28,410 | 10-Q, filed 2014-05-14 | ||
| 2013-12-31 | $28,410 | 10-K, filed 2014-03-21 | ||
| 2013-09-30 | $28,410 | 10-Q, filed 2013-11-13 | ||
| 2013-06-30 | $28,410 | 10-Q, filed 2013-08-12 | ||
| 2013-03-31 | $28,410 | 10-Q, filed 2013-05-09 | ||
| 2012-12-31 | $28,410 | 10-K, filed 2013-03-22 | ||
| 2012-09-30 | $28,410 | 10-Q, filed 2012-11-08 | ||
| 2012-06-30 | $28,410 | 10-Q, filed 2012-08-08 | ||
| 2012-03-31 | $28,410 | 10-Q, filed 2012-05-09 | ||
Key facts
CIK
1228627
CUSIP
67577R102
13F (30d)
14 filings
14 filers
Visit website
Investor relations